CHAPEL HILL, N.C., Aug. 15, 2014 /PRNewswire/ --The Medical Affairs function has begun to play an increasingly important role in clinical development, market education, and regulatory compliance, as the healthcare landscape changes.

The Medical Affairs Consortium at Best Practices, LLC is designed to give Medical Affairs leaders a forum for sharing insights about the key challenges they face and provide a mechanism for creating and sharing solutions. Through three virtual roundtable discussions over a year, Medical Affairs leaders learn about how their peers address key issues, discuss potential solutions, and gain valuable insights.

Best Practices, LLC is in the data collection stage of the Medical Affairs Consortium and the survey was launched on Wednesday, August 13th.

Please click on the link to take the survey: http://www.surveygizmo.com/s3/1714147/2014-2015-Medical-Affairs-Consortium-Developing-Top-Tier-Medical-Affairs-Capabilities

This year's research topics may include, but are not limited to:

Benefits of Participation: All survey participants will receive the important findings with charted results and analysis.

Deadline: Friday, September 5th

Research from Best Practices' 2014-2015 Medical Affairs Consortium will provide leaders with an evidence-based understanding of current and evolving approaches to the most important Medical Affairs challenges. Current consortium members include, but are not limited to: Astellas, Baxter, Eli Lilly, ProStrakan, Sanofi, Teva and Upsher-Smith.

For more information regarding the Medical Affairs Consortium studies, please review our Weekly Medical Affairs Consortium Research Release.

To learn more about Medical Affairs Consortium, click on the following link:http://www.best-in-class.com/medical-affairs-consortium.

View original post here:
Best Practices Launches 2014-2015 Medical Affairs Consortium Survey

Related Posts
August 16, 2014 at 9:02 am by Mr HomeBuilder
Category: Landscape Hill